医院产超广谱β-内酰胺酶大肠埃希菌临床分布及其耐药性的分析

王姣平, 周发为

中国医院药学杂志 ›› 2016, Vol. 36 ›› Issue (13) : 1121-1124.

PDF(617 KB)
PDF(617 KB)
中国医院药学杂志 ›› 2016, Vol. 36 ›› Issue (13) : 1121-1124. DOI: 10.13286/j.cnki.chinhosppharmacyj.2016.13.20
药物与临床

医院产超广谱β-内酰胺酶大肠埃希菌临床分布及其耐药性的分析

  • 王姣平, 周发为
作者信息 +

Analysis of clinical distribution and drug resistance of extended spectrum β-lactamases producing Escherichia coli

  • WANG Jiao-ping, ZHOU Fa-wei
Author information +
文章历史 +

摘要

目的:讨论医院产ESBLs (超广谱β-内酰胺酶)大肠埃希菌临床分布情况,并对其进行耐药性分析,为临床医师合理选用抗菌药物提供依据。方法:以某院2012年1月-2015年1月各个临床科室送检的标本中分离724株大肠埃希菌作为研究对象,采用表型确证试验检测ESBLs,并分析其分布及耐药性情况。结果:某院自2012年1月-2015年1月共检出724株大肠埃希菌;感染部位以分泌物来源最为常见,分布的主要科室是呼吸科(含ICU)、普外科及肾内科。共分离得到产ESBLs菌株248株(34.3%);产ESBLs大肠埃希菌对美罗培南以及亚胺培南均无耐药性,而对于其他抗菌药物,其耐药率则均明显高于不产ESBLs大肠埃希菌。结论:产ESBLs大肠埃希菌具有较强的耐药性,临床应加强对其耐药性及感染率的监测。

Abstract

OBJECTIVE To investigate clinical distribution and drug resistance of hospital extended spectrum β-lactamase (ESBLs) producing Escherichia coli.METHODS A total of 724 clinical isolates of Escherichia coli in our hospital from January 2012 to January 2015 were collected to perform antimicrobial susceptibility test, ESBLs screening and confirmatory test.Clinical distribution and drug resistance were statistically analyzed.RESULTS Of 724 strains of Escherichia coli, positive rate of ESBLs-production was 34.3% (248 stains).Bacterial strains were mainly distributed in pneumology department (including ICU), general surgery department and gynecology department.ESBLs-producing Escherichia coli had no drug resistance to meropenem and imipenem.For other drugs, resistant rate ESBLs-producing strains was higher than that of no ESBLs-producing stains.CONCLUSION Detection rate of ESBLs-producing Escherichia coli shows multiple drug resistance.These ESBLs-producing strains are distributed in various samples in different wards.Clinical distribution and drug resistance characteristics of bacterial strains should be grasped timely to use antibiotics rationally to control transmission and prevalence of ESBLs- producing strains.

关键词

抗菌药物 / 临床分布 / 耐药性 / 超广谱β-内酰胺酶 / 大肠埃希菌

Key words

extended spectrum β-lactamase / clinical distribution / Escherichia coli / antibiotics / drug resistance

引用本文

导出引用
王姣平, 周发为. 医院产超广谱β-内酰胺酶大肠埃希菌临床分布及其耐药性的分析[J]. 中国医院药学杂志, 2016, 36(13): 1121-1124 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2016.13.20
WANG Jiao-ping, ZHOU Fa-wei. Analysis of clinical distribution and drug resistance of extended spectrum β-lactamases producing Escherichia coli[J]. Chinese Journal of Hospital Pharmacy, 2016, 36(13): 1121-1124 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2016.13.20
中图分类号: R978.1   

参考文献

[1] Livermore DM.Current epidemiology and growing resistance of gram-negative pathogens[J].Korean J Inter Med, 2012, 27(2):128-142.
[2] 叶燕崧, 梁杰昌.尿路感染产超广谱β-内酰胺酶大肠埃希菌耐药性分析[J].中华全科医学, 2013, 11(6):947-948.
[3] 张小莉, 文怡, 梅亚宁, 等.2011年医院病原菌分布及耐药性监测[J].中华医院感染学杂志, 2014, 24(6):1347-1349.
[4] 张昭勇, 吕军, 张吉才.临床分离大肠埃希菌耐药性及产超广谱β-内酰胺酶株危险因素分析[J].现代预防医学, 2013, 40(13):2561-2563, 2568.
[5] 王倩, 孙国全, 田素飞, 等.外科ICU产ESBLs大肠埃希菌感染临床调查及耐药性分析[J].中华医院感染学杂志, 2013, 23(17):4279-4280, 4283.
[6] 邱格辉, 潘命芝.革兰阴性杆菌产超广谱β-内酰胺酶状况及其耐药性监测[J].中国实用医药, 2011, 6(11):28-29.
[7] 龚小明, 何娟妃.大肠埃希菌的耐药性及产超广谱β-内酰胺酶分析[J].中华医院感染学杂志, 2013, 23(5):1147-1148, 1165.
[8] 姜梅杰, 孙启英, 刘广丽.472株大肠埃希菌分布及耐药性分析[J].中华医院感染学杂志, 2012, 22(10):2192-2193.
[9] 徐小群, 俞增仙, 董春富.ICU老年患者气管切开后的痰病原菌培养与药敏分析[J].中华医院感染学杂志, 2011, 21(4):812-814.
[10] 陈子松.产超广谱β-内酰胺酶ECO与KPN的检测及耐药性分析[J].中华医院感染学杂志, 2009, 19(8):998-999.
[11] 凌丽燕.产超广谱β-内酰胺酶ECO的检测及耐药性分析[J].中华医院感染学杂志, 2011, 21(5):1016-1018.
[12] 寇新明, 潘靖, 吴金英, 等.大肠埃希菌耐药性及耐药基因检测[J].中华医院感染学杂志, 2008, 18(10):1357-1360.
[13] 叶应妩, 王毓三, 申子瑜.全国临床检验操作规程[M].南京:东南大学出版社, 2006:755-885.
[14] 胡必杰, 郭燕红, 高光明.医院感染预防与控制标准标准操作规程(参考版)[M].上海:上海科学技术出版社, 2010:7.
[15] Page MG.Extended-spectrum beta-lactamases:structure and kinetic mechanism[J].Clin Microbiol Infect, 2008, 14(Suppl 1):63-74.

PDF(617 KB)

Accesses

Citation

Detail

段落导航
相关文章

/